Jonathan C. Chan

Vancouver, BC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Outcomes of a Canadian real-world cohort of metastatic castration-sensitive prostate cancer patients stratified by early PSA nadir.

Outcomes of a Canadian real-world cohort of metastatic castration-sensitive prostate cancer patients stratified by early PSA nadir.

Journal: Future oncology (London, England)

Published: June 19, 2026

Reply.

Reply.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: June 04, 2025

Residual Disease Activity and Burden of Disease in Canadian Patients With Axial Spondyloarthritis: Results From a Multiregistry Analysis (UNISON-Axial SpA).

Residual Disease Activity and Burden of Disease in Canadian Patients With Axial Spondyloarthritis: Results From a Multiregistry Analysis (UNISON-Axial SpA).

Journal: The Journal of rheumatology

Published: May 07, 2025

Canadian Patients With Axial Spondyloarthritis Require Almost a Decade To Be Diagnosed Leading to Severe Functional Limitation. Results From the International Map of Axial Spondyloarthritis (IMAS).

Canadian Patients With Axial Spondyloarthritis Require Almost a Decade To Be Diagnosed Leading to Severe Functional Limitation. Results From the International Map of Axial Spondyloarthritis (IMAS).

Journal: Musculoskeletal care

Published: October 22, 2024

Prodrug Nanomedicine for Synovium Targeted Therapy of Inflammatory Arthritis: Insights from Animal Model and Human Synovial Joint Fluid.

Prodrug Nanomedicine for Synovium Targeted Therapy of Inflammatory Arthritis: Insights from Animal Model and Human Synovial Joint Fluid.

Journal: Advanced healthcare materials

Published: May 25, 2024

Granzyme B cleaves tenascin-C to release its C-terminal domain in rheumatoid arthritis.

Granzyme B cleaves tenascin-C to release its C-terminal domain in rheumatoid arthritis.

Journal: JCI insight

Published: April 11, 2024

Features of Axial Spondyloarthritis in Two Multicenter Cohorts of Patients with Psoriasis, Uveitis, and Colitis Presenting with Undiagnosed Back Pain.

Features of Axial Spondyloarthritis in Two Multicenter Cohorts of Patients with Psoriasis, Uveitis, and Colitis Presenting with Undiagnosed Back Pain.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: March 12, 2024

Developing International Classification of Disease code definitions for the study of enteric infection sequelae in Canada.

Developing International Classification of Disease code definitions for the study of enteric infection sequelae in Canada.

Journal: Canada communicable disease report = Releve des maladies transmissibles au Canada

Published: March 08, 2024

Residual Disease Activity in Canadian Patients With Psoriatic Arthritis Treated With Advanced Therapies: Results From a Multiregistry Analysis (UNISON-PsA).

Residual Disease Activity in Canadian Patients With Psoriatic Arthritis Treated With Advanced Therapies: Results From a Multiregistry Analysis (UNISON-PsA).

Journal: The Journal of rheumatology

Published: January 10, 2024

Real-World Effectiveness of Upadacitinib for Treatment of Rheumatoid Arthritis in Canadian Patients: Interim Results from the Prospective Observational CLOSE-UP Study.

Real-World Effectiveness of Upadacitinib for Treatment of Rheumatoid Arthritis in Canadian Patients: Interim Results from the Prospective Observational CLOSE-UP Study.

Journal: Rheumatology and therapy

Published: December 17, 2023

Work-Related Issues and Physical and Psychological Burden in Canadian Patients With Axial Spondyloarthritis: Results From the International Map of Axial Spondyloarthritis.

Work-Related Issues and Physical and Psychological Burden in Canadian Patients With Axial Spondyloarthritis: Results From the International Map of Axial Spondyloarthritis.

Journal: The Journal of rheumatology

Published: November 11, 2022

A Retrospective Study on the Effectiveness of Ixekizumab After Treatment With Secukinumab for Patients With Active Psoriatic Arthritis.

A Retrospective Study on the Effectiveness of Ixekizumab After Treatment With Secukinumab for Patients With Active Psoriatic Arthritis.

Journal: Journal of psoriasis and psoriatic arthritis

Published: January 01, 2022

Showing 1-12 of 25

Last Updated: 09/26/2026